Pharmather Holdings Ltd
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia… Read more
Market Cap & Net Worth: Pharmather Holdings Ltd (PHRRF)
Pharmather Holdings Ltd (OTCQB:PHRRF) has a market capitalization of $12.11 Million ($12.11 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #30850 globally and #10162 in its home market, demonstrating a -16.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharmather Holdings Ltd's stock price $0.13 by its total outstanding shares 91019065 (91.02 Million).
Pharmather Holdings Ltd Market Cap History: 2020 to 2025
Pharmather Holdings Ltd's market capitalization history from 2020 to 2025. Data shows change from $21.77 Million to $12.11 Million (-6.69% CAGR).
Pharmather Holdings Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharmather Holdings Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PHRRF by Market Capitalization
Companies near Pharmather Holdings Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Pharmather Holdings Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Pharmather Holdings Ltd Historical Marketcap From 2020 to 2025
Between 2020 and today, Pharmather Holdings Ltd's market cap moved from $21.77 Million to $ 12.11 Million, with a yearly change of -6.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $12.11 Million | -22.67% |
| 2024 | $15.66 Million | -28.33% |
| 2023 | $21.84 Million | +421.74% |
| 2022 | $4.19 Million | -83.63% |
| 2021 | $25.58 Million | +17.47% |
| 2020 | $21.77 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pharmather Holdings Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.11 Million USD |
| MoneyControl | $12.11 Million USD |
| MarketWatch | $12.11 Million USD |
| marketcap.company | $12.11 Million USD |
| Reuters | $12.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.